Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar;24(135):102-14.
doi: 10.1183/09059180.00003214.

Cellular interactions in the pathogenesis of interstitial lung diseases

Affiliations
Review

Cellular interactions in the pathogenesis of interstitial lung diseases

Gianluca Bagnato et al. Eur Respir Rev. 2015 Mar.

Abstract

Interstitial lung disease (ILD) encompasses a large and diverse group of pathological conditions that share similar clinical, radiological and pathological manifestations, despite potentially having quite different aetiologies and comorbidities. Idiopathic pulmonary fibrosis (IPF) represents probably the most aggressive form of ILD and systemic sclerosis is a multiorgan fibrotic disease frequently associated with ILD. Although the aetiology of these disorders remains unknown, in this review we analyse the pathogenic mechanisms by cell of interest (fibroblast, fibrocyte, myofibroblast, endothelial and alveolar epithelial cells and immune competent cells). New insights into the complex cellular contributions and interactions will be provided, comparing the role of cell subsets in the pathogenesis of IPF and systemic sclerosis.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
This schematic view of the morpho-functional unit of the lung (alveolus) depicts the main differences in cellular composition in idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease (SSc-ILD) compared with normal physiological cellular components. Th2: T-helper cell type 2; AEC: alveolar epithelial cell.
FIGURE 2
FIGURE 2
Cellular players and molecules in idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated interstitial lung disease. Cells inside dashed lines are relevant to IPF pathogenesis only. ROS: reactive oxygen species; TGF: transforming growth factor; IL: interleukin; MCP: monocyte chemotactic protein; PDGF: platelet-derived growth factor; ET: endothelin; PMNC: peripheral blood mononuclear cell; EMT: epithelial–mesenchymal transition; CTGF: connective tissue growth factor; Th2: T-helper cell type 2; AEC: alveolar epithelial cell; PMC: pleural mesothelial cell.

References

    1. Cottin V. Interstitial lung disease. Eur Respir Rev 2013; 22: 26–32. - PMC - PubMed
    1. Travis WD, Costabel U, Hansell DM, et al. . An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733–748. - PMC - PubMed
    1. Lederer DJ. Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward. Eur Respir J 2013; 42: 1446–1448. - PubMed
    1. Carrington CB, Gaensler EA, Coutu RE, et al. . Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298: 801–809. - PubMed
    1. Harari S, Caminati A.. IPF: new insight on pathogenesis and treatment. Allergy 2010; 65: 537–553. - PubMed